Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs13361160
rs13361160
C 0.800 GeneticVariation GWASCAT Genome-wide association study meta-analysis of chronic widespread pain: evidence for involvement of the 5p15.2 region. 22956598

2013

dbSNP: rs13361160
rs13361160
C 0.800 GeneticVariation GWASDB Genome-wide association study meta-analysis of chronic widespread pain: evidence for involvement of the 5p15.2 region. 22956598

2013

dbSNP: rs17122021
rs17122021
0.800 GeneticVariation GWASDB Genome-wide association study of acute post-surgical pain in humans. 19207018

2009

dbSNP: rs17122021
rs17122021
0.800 GeneticVariation GWASCAT Genome-wide association study of acute post-surgical pain in humans. 19207018

2009

dbSNP: rs2562456
rs2562456
0.800 GeneticVariation GWASDB Genome-wide association study of acute post-surgical pain in humans. 19207018

2009

dbSNP: rs2562456
rs2562456
0.800 GeneticVariation GWASCAT Genome-wide association study of acute post-surgical pain in humans. 19207018

2009

dbSNP: rs1057518927
rs1057518927
OAT
C 0.700 GeneticVariation CLINVAR

dbSNP: rs1057518946
rs1057518946
T 0.700 GeneticVariation CLINVAR

dbSNP: rs121908552
rs121908552
A 0.700 GeneticVariation CLINVAR

dbSNP: rs1554781700
rs1554781700
T 0.700 GeneticVariation CLINVAR

dbSNP: rs1972597
rs1972597
G 0.700 GeneticVariation GWASCAT Genome-wide association study suggests common variants within RP11-634B7.4 gene influencing severe pre-treatment pain in head and neck cancer patients. 27670397

2016

dbSNP: rs3862188
rs3862188
G 0.700 GeneticVariation GWASCAT We identified 3 common genetic variants in high linkage disequilibrium for severe pre-treatment pain, representing one genomic region at 1q44 (rs3862188, P = 3.45 × 10<sup>-8</sup>; rs880143, P = 3.45 × 10<sup>-8</sup>; and rs7526880, P = 4.92 × 10<sup>-8</sup>), which maps to the RP11-634B7.4 gene, a novel antisense gene to three olfactory receptor genes. 27670397

2016

dbSNP: rs1799971
rs1799971
0.100 GeneticVariation BEFREE Genetic variants in OPRM1, particularly the non-synonymous polymorphism A118G, have been repeatedly associated with the efficacy of treatments for pain and various types of dependence. 24201053

2014

dbSNP: rs1799971
rs1799971
0.100 GeneticVariation BEFREE The most pronounced N40D effects were found in brain regions involved in the sensory processing of pain intensity. 19116204

2009

dbSNP: rs1799971
rs1799971
0.100 GeneticVariation BEFREE This OPRM1 A118G-DPMS interaction is one plausible neurological mechanism underlying the individual differences in pain experience. 28057931

2017

dbSNP: rs1799971
rs1799971
0.100 GeneticVariation BEFREE Single-nucleotide polymorphisms in OPRM1 gene (opioid receptor, A118G), ABCB1 gene (opioid transporter, C3435T), COMT gene (pain sensitivity, G1947A), and UGT2B7 gene (opioid metabolism, -G840A) were tested. 25576257

2015

dbSNP: rs1799971
rs1799971
0.100 GeneticVariation BEFREE µ-opioid receptor gene variant OPRM1 118 A>G: a summary of its molecular and clinical consequences for pain. 24236490

2013

dbSNP: rs1799971
rs1799971
0.100 GeneticVariation BEFREE The results indicate that among the genetic SNPs we studied which include those affecting analgesic drug metabolism, transport of analgesic agents across the blood-brain barrier, and their activity at target receptors and ion channels and in the modulation of neurotransmitter pathways, the A118G allele variant of OPRM1 has the most potent influence on pain management of postoperative patients. 25794200

2015

dbSNP: rs1799971
rs1799971
0.100 GeneticVariation BEFREE Regarding the A118G SNP in exon 1, in a cold pressor-induced pain test before surgery, less analgesic effects of fentanyl were shown in subjects carrying the minor G allele of the A118G SNP (median of difference between pain perception latencies before and after fentanyl injection [PPLpost-PPLpre]: 12s) compared with subjects not carrying this allele (PPLpost-PPLpre: 15s, p=0.046). 19783098

2009

dbSNP: rs1799971
rs1799971
0.100 GeneticVariation BEFREE This discourages basing personalized therapeutic concepts of pain therapy on OPRM1 118A>G genotyping at the present state of evidence. 19683391

2009

dbSNP: rs1799971
rs1799971
0.100 GeneticVariation BEFREE Polymorphisms of OPRM1 A118G and ABCB1 C3435T have been suggested to contribute to inter-individual variability regarding pain sensitivity, opioid usage, tolerance and dependence and incidence of adverse effects in patients with chronic pain. 23803057

2013

dbSNP: rs1799971
rs1799971
0.100 GeneticVariation BEFREE No association was found between 118A>G and experimental pain 25239082

2014

dbSNP: rs1799971
rs1799971
0.100 GeneticVariation BEFREE Patients homozygous for the variant G allele of the 118 A > G polymorphism (n = 4) needed more morphine to achieve pain control, compared to heterozygous (n = 17) and homozygous wild-type (n = 78) individuals. 15504181

2004

dbSNP: rs1799971
rs1799971
0.100 GeneticVariation BEFREE In a subpopulation, identifying OPRM1 A118G polymorphism may provide valuable information regarding the individual analgesic doses that are required to achieve satisfactory pain control. 25102313

2014

dbSNP: rs1799971
rs1799971
0.100 GeneticVariation BEFREE In comparison, two pain-related gene SNPs (OPRM1 [rs1799971] and COMT [rs4818]) interacted with psychological factors to predict four shoulder impairment phenotypes (abduction: 5-day average loss; strength loss: 5-day average, peak, and relative loss). 30425562

2018